Back to top
more

Chemed (CHE)

(Delayed Data from NYSE)

$584.89 USD

584.89
60,722

-1.28 (-0.22%)

Updated Sep 3, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 21% (52 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) on strong third-quarter 2021 results and raised full-year outlook.

Thermo Fisher (TMO) Launches K-12 COVID-19 Test in Texas Schools

Thermo Fisher's (TMO) ReadyCheckGo program will enable Texas schools to have the options for fast, reliable testing to identify and limit the spread of COVID-19 quickly.

Abbott (ABT) Nutrition Sales Strong Amid Spike in COVID Cases

Abbott (ABT) is registering strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.

The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp

The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp

Quest Diagnostics (DGX) Expands Testing Suite With NGS Test

Quest Diagnostics (DGX) offers Targeted Lung Panel Test at 2,200 conveniently located patient service centers across the United States.

Riya Anand headshot

4 MedTech Dividend Stocks in Focus on Amid Omicron Variant Panic

Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.

DaVita (DVA) Study Favors mRNA Vaccines for Dialysis Patients

DaVita's (DVA) latest study indicates favorable outcomes for ESKD patients regarding the COVID-19 vaccines.

Masimo's (MASI) Rad-G Clinical Study Trial Outcome Favorable

Masimo's (MASI) latest study results demonstrate that Rad-G Pulse Oximeter can help detect pediatric pneumonia.

3 Reasons to Retain Integer Holdings (ITGR) Stock For Now

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and its focus on growth strategies.

SeaSpine (SPNE) Enhances ACDF Procedure With Admiral ACP System

SeaSpine's (SPNE) next-generation Admiral ACP System covers the largest segment in the estimated $1.30-billion cervical spine surgery market.

Here's Why You Should Add Hill-Rom (HRC) to Your Portfolio

Investors are optimistic about Hill-Rom (HRC) on strong fiscal fourth-quarter results and progress in digital health.

Here's Why You Should Retain Abbott (ABT) Stock For Now

Investors are optimistic about Abbott (ABT) owing to strong third-quarter results and bullish 2021 outlook.

Bio Rad (BIO) Grows Internationally on New Product Launches

Strength in Bio Rad's (BIO) key product lines across major geographic regions buoys optimism.

Here's Why You Should Invest in Bio-Rad (BIO) Stock Now

Investors are optimistic about Bio-Rad (BIO) on strength in its key product lines and raised 2021 guidance.

CVS Health (CVS) Installs Time-Delay Safes in Texas Pharmacies

CVS Health's (CVS) time-delay safes reduce theft and diversion of opioid medications and boost the security of stores, creating a safe environment for patients and staff.

Alcon (ALC) Surgical Arm Grows Amid Global Trade Disruption

Segment wise, within Alcon's (ALC) Surgical arm, the portfolio of advanced technology intraocular lenses is driving increased penetration rates of ATIOLs.

Illumina's (ILMN) New Alliance to Accelerate Genomics in China

Illumina's (ILMN) Genomics Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics.

Here's Why You Should Buy Thermo Fisher (TMO) Stock Now

Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.

Veeva Systems (VEEV) Digital Tools Boost Patient Engagement

Veeva Systems' (VEEV) enhancements in digital tools incorporate new ways for seamless communication among healthcare providers and field teams.

Zimmer Biomet's (ZBH) Recovery Slows in Americas Amid Pandemic

The third quarter brings greater COVID-related pressure than expected for Zimmer Biomet (ZBH).

CVS Health's (CVS) New Measures to Boost Omnichannel Health

CVS Health's (CVS) new measures will support its strategy of making health care more affordable, accessible and convenient for consumers.

LabCorp (LH) to Expand Nonclinical Development With New Buyout

LabCorp's (LH) acquisition of Toxikon can expand its full-service drug development and medical device solutions portfolio.

Phibro (PAHC) Sales Hurt by Staffing Shortage Amid Pandemic

Internationally, Phibro (PAHC) is registering growth in nutritional specialties driven by strong sales of dairy products.

Masimo (MASI) Reports SedLine's Psi & DSA Parameter Findings

The study findings show that monitoring with Masimo (MASI) SedLine Brain Function Monitoring parameters during CEA surgery can reduce the risk of postoperative delirium.

Intersect ENT's (XENT) Sell-Off on Track Amid COVID Woes

Amid industry-wide concerns of deferral of elective procedures, Intersect ENT's (XENT) plans to consolidate with an industry behemoth like Medtronic seems a strategically aligned survival plan.